Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension

Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension

NCT04483115 ·Status: COMPLETED ·Phase: PHASE2

A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).

NCT01305252 ·Status: COMPLETED ·Phase: PHASE4

Treprostinil Combined With Tadalafil for Pulmonary Hypertension

NCT01302444 ·Status: TERMINATED ·Phase: PHASE4

A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension

NCT00853112 ·Status: TERMINATED ·Phase: PHASE2

The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.

NCT05908019 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension

NCT03139084 ·Status: WITHDRAWN

Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension

NCT03309592 ·Status: WITHDRAWN ·Phase: PHASE4

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

NCT05179876 ·Status: RECRUITING ·Phase: PHASE3

Tadalafil for Sarcoidosis Associated Pulmonary Hypertension

NCT01324999 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities

NCT07245680 ·Status: RECRUITING ·Phase: PHASE3

Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

NCT04266197 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension

NCT02558231 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

NCT02725372 ·Status: TERMINATED ·Phase: PHASE3

Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen

NCT03135860 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults

NCT00581087 ·Status: UNKNOWN ·Phase: PHASE3

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

NCT03496623 ·Status: TERMINATED ·Phase: PHASE3

Comparison of Sequential to Initial Combination Therapy in PAH

NCT06968962 ·Status: RECRUITING ·Phase: NA

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT03904693 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)

NCT01553721 ·Status: COMPLETED ·Phase: PHASE2

Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes

NCT03081052 ·Status: COMPLETED ·Phase: PHASE4

A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension

NCT05343637 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension

NCT00718952 ·Status: COMPLETED ·Phase: PHASE3

FK506 (Tacrolimus) in Pulmonary Arterial Hypertension

NCT01647945 ·Status: COMPLETED ·Phase: PHASE2

A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234

NCT05567367 ·Status: COMPLETED ·Phase: PHASE1

Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH

NCT02484807 ·Status: COMPLETED